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Objective: To determine the factors associated with pain relief and
improved physical functioning in chronic pain patients during
outpatient management in the first 5 months immediately after a
standardized inpatient pain management program.
Methods: Prospective cohort study using standardized questionnaires
on sociodemographic data, disease outcome, psychosocial factors,
change in behavior, and outpatient therapies on discharge from
inpatient rehabilitation and during the 5-month follow-up at home
(observation period). Stepwise forward multivariate linear regression
analysis examined the correlation of these factors with change in pain
severity and change in physical functioning.
Results: The study included 80.1% female patients, 90.0% had at
least 1 comorbidity and 62.9% had chronic pain forZ5 years. On
average, pain intensity and depression worsened slightly during the
observation period, but the other outcomes remained almost stable.
Relief from anxiety (20.7% explained variance) and low baseline
depression (5.5%) were the most important predictors for pain
relief. Relief from anxiety (13.3%) and low baseline depression
(7.1%) were most strongly associated with functional improvement.
Conclusions: This study found a strong association of change in
pain severity and physical functioning with change in baseline level
of affective health and coping during the first outpatient manage-
ment period after inpatient rehabilitation. As a consequence, it may
be possible to improve the treatment of chronic pain by therapy of
mood and coping.
Key Words: chronic pain, pain severity, physical functioning,
depression, anxiety
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Chronic pain is a major health care problem in Europe.Nineteen percent of adult Europeans report chronic pain
of moderate to severe intensity and are seriously affected
with regard to the quality of their social and working
lives.1 Fifty percent of chronic pain patients also report
depression in contrast to 2% to 9% of the general pop-
ulation.2 Patients with this comorbidity have more severe
pain outcomes than those with chronic pain alone.3 Thirty-
nine percent of the patients who consulted a general
practitioner with a new episode of low back pain reported
persistent disabling pain at follow-up 3 months later.4
The most helpful factors to predict persistent disabling
low back pain are maladaptive pain-coping behaviors,
presence of nonorganic signs, high functional impairment,
low general health status, and the presence of psychiatric
comorbidities.5 Low levels of fear avoidance and low
baseline functional impairment were the most useful items
for predicting recovery at 1 year. One of the most accepted
models for the development of chronic low back pain is the
model of fear avoidance.6 Pain catastrophizing leads to the
fear of movement, which is followed by an avoidance
behavior like inactivity, reduced mobility, increased dis-
ability, and, furthermore, anxiety and depression. Con-
sequently, reduction of fear and avoidance by informing
about the nonserious nature of pain led to a better outcome
with respect to pain intensity and physical functioning.6
Chronic pain patients show high variation of symptom
patterns and therefore need individually adapted and specific
therapies. Treatment of depression improved mental health
and reduced the effects of pain on work among patients with
chronic pain and depression.3 In our previous study, which
included data from some of the patients being reexamined in
the present study, we concluded at the end of the study that
patients who participated in the specialized inpatient inter-
disciplinary program reported greater improvement on pain,
social functioning, trend for improvement in catastrophizing,
and ability to decrease pain compared with the group
receiving standard inpatient rehabilitation.7 However, at the
6-month follow-up, the standard rehabilitation group showed
greater improvements on physical function, social function,
anxiety, and life control when compared with the inter-
disciplinary pain program.
Consistently, other studies showed the superiority of
interdisciplinary pain programs when compared with con-
trol groups.8,9 Multidisciplinary treatment of fibromyalgia
delivered greater improvements compared with single
therapies.10 However, we could not find any studies that
examined the effect of outpatient therapies given immedi-
ately after inpatient treatment.
The purpose of this study was to determine the predictive
factors for pain relief and functional improvement in chronic
pain patients (back pain and widespread pain) in the period at
home immediately after completing a comprehensive inpatient
rehabilitation program. These findings should help to opti-
mize outpatient management after discharge. Pain severity
and physical function have been considered the most impor-
tant dimensions of chronic pain syndrome, decisive for man-
aging daily life. They were highly responsive in our previous
outcome studies.11
MATERIALS AND METHODS
Patients and Interventions
From 1999 to 2007 patients were consecutively refer-
red by general practitioners, rheumatologists, and hospitals
to a specialized inpatient interdisciplinary pain program or
standard rehabilitation.7,12 The “Zurzach Interdisciplinary
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Pain (German: Schmerz) Program” comprises medical care
including drug therapy, graded activity exercises, single
psychotherapy, and different group therapies. The program
is very intensive, comprises an average of 6 sessions of different
(single and group) therapies per day and lasts 4 weeks.
Standard rehabilitation provides approximately the same
therapeutic entities without the group therapies and lasts 3
weeks. The main difference was that patients receiving stand-
ard rehabilitation required and received far less psychological
therapy.
A detailed description and comparison of the 2 inter-
ventions were given in our previous report (Angst et al7: see
Table 1). After discharge, ambulatory care was organized
for each patient by the treating physician of the clinic and
the general practitioner who continued the management.
The management after discharge consisted of consultations
at the general practitioner to adapt medication, active and
passive physiotherapies, and consultations at the psychol-
ogist/psychiatrist. The main medical therapies comprised
analgesics such as paracetamol, nonsteroidal anti-inflam-
matory drugs, opioids, opiates, and metamizol and also
antidepressants as tricyclics, selective serotonin reuptake
inhibitors, serotonin and norepinephrine reuptake inhib-
itors, mianserin, and mirtazapine. Interventions are listed in
Table 2. In addition, changes in psychological factors have
been recorded.
Patients had a history of chronic pain either due to
back pain (in most cases, low back pain) or general wide-
spread pain (including fibromyalgia according to American
College of Rheumtology (ACR criteria). All had a history
of failed outpatient therapy. Patients with severe somatic
illness or severe manifestation of psychiatric disorder that
prevented them from participating in the treatment pro-
gram were excluded. Participating patients were able to
formulate realistic functional goals and agreed to attend the
program regularly. Detailed information about inclusion
and exclusion criteria was previously reported.7,12
Measures
We assessed outcomes at discharge from the clinic
(baseline) and during the 5 months after discharge from
inpatient rehabilitation at home (follow-up), using the same
self-assessment forms listed below. In addition, various
sociodemographic and disease-relevant parameters were
recorded from patients’ medical records (reports were sent to
the referring physicians to inform them about the inpatient
rehabilitation program as well as cofactors, comorbidities,
and medication on discharge7,12; see also Tables 1 and 2).
The standardized self-assessed outcome instruments
used in this study has been previously described.12 The
Multidimensional Pain Inventory (MPI) is a comprehensive
instrument for the assessment of chronic pain and its con-
sequences in terms of function, mood, and social inter-
action.13,14 We used the scales MPI pain severity (3 items)
and MPI activity (total score of all 18 activity items). MPI
activity measures social and leisure activities and indoor
and outdoor activities of daily living. Subgroups with spe-
cific symptom patterns can be determined by cluster anal-
ysis of the 9 main MPI scales. They may have consequences
for disease management.15,16 The Interpersonally Dis-
tressed subgroup perceives a low level of support from the
partner and social environment. Adaptive Copers are
characterized by relatively low pain intensity and relatively
low interference of pain (functional interference). The
Dysfunctional subgroup reports high pain severity, low
function, high depression, and low life control.
The Short-Form 36 questionnaire (SF-36) compre-
hensively measures physical, mental, and psychosocial
health by means of 36 items.17,18 We used the SF-36
physical functioning scale (10 items) as a dependent varia-
ble as it mainly covers questions on mobility, which is
crucial to independence. It also turned out to be more
responsive compared with the MPI activity score.7,11,12
The Hospital Anxiety and Depression Scale (HADS)
provided the 2 scales—depression and anxiety (7 items
each)—both of which play an important role in chronic
pain syndrome.19,20 HADS was developed specifically for
nonpsychiatric conditions and has a long history of appli-
cation in medicine. It has been successfully used in large
populations and patient surveys.21,3
The Coping Strategy Questionnaire (CSQ) assesses cog-
nitive and behavioral strategies to manage chronic pain and
their consequences for daily life.22,23 From this tool, we used
the following scales: catastrophizing (6 items), ability to
decrease pain (1 item), an ability to control pain (1 item).
These 3 scales emerged as the most responsive scores in our
outcome study.12
Analyses
Assessments were performed on discharge from the
clinic after the inpatient rehabilitation program and five
month later at home. This was the period when the patient
was under outpatient management prescribed by the clinic
at discharge. The management was continued by the gen-
eral practitioner. To compare score data, all scales of the
questionnaires were transformed into a scale from 0 to 100.
Zero was the worst score for the given situation, for
example, maximum pain, no function, and maximum
depression. A score of 100 denoted no pain, maximum
function, and no depression. Descriptive data of all
parameters and scores are listed in Tables 1 and 2.
We used stepwise forward multivariate linear regression
analysis to determine the predictive factors. The dependent
variables were change in pain severity (MPI) and change in
physical functioning (SF-36) in the period between discharge
from the clinic (baseline) and the 5-month follow-up at home
(follow-up). As independent variables we applied the baseline
scores of each dependent variable: MPI pain at discharge from
the clinic and SF-36 physical function at discharge from the
clinic. As psychological factors we examined the influence (ie,
the baseline and difference values, respectively) of HADS
anxiety, HADS depression, CSQ catastrophizing, CSQ
decrease pain, CSQ control pain, and MPI activity. The fol-
lowing therapeutic interventions were assessed: antidepressants
(baseline and difference), analgesics (baseline and difference),
number of active and passive physiotherapies (during obser-
vation period), number of consultations of general practitioner
and psychiatrist (during observation period), and sports task
(baseline and difference). The sociodemographic independent
factor was working capacity (baseline and difference). Steady
sociodemographic independent factors were: education, age,
sex, living with partner or not, and smoking. To some extent,
stable medical independent factors were body mass index,
number of comorbidities, diagnosis, MPI subgroups, and
intention to be more active (data for the last item were pro-
vided 2 months after discharge from inpatient rehabilitation).
Because of the heuristic relationship between pain and
function, the SF-36 physical functioning score was left out
of the regression of change in pain and, vice versa, MPI
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pain severity was left out of the regression of change in
function. Otherwise, it is likely that much of the change in
function would be explained by the change in pain and the
other way round.
For stepwise inclusion, the covariable had to be pre-
dictive for the dependent variable by P<0.30 (the P-out).
To be retained in the final model, every factor had to be
predictive by P<0.10 (the P-in). The final model thereafter
provided the predictive influence of each single covariable
controlled for the predictive influence of all other covari-
ables.24,25 The final model should not contain more than
n/10 covariables (where, n=number of patients) to result
in a finite model and valid data.26 All analyses were per-
formed using the statistical software package SPSS 18.0 for
Windows (SPSS Inc., Chicago, IL).
RESULTS
Patients
The cohort comprised 429 chronic pain patients who
were recruited between 1999 and 2007. One hundred
twenty-one of them had incomplete data at 5-month follow-
up at home. Of the remaining 308 patients, 17 were
excluded because the diagnosis was not low back pain or
widespread pain. Complete data were available for 291
relevant chronic pain patients.
Table 1 shows the sociodemographic and disease-rel-
evant parameters at discharge from the clinic. Most of the
patients were female (80.1%). About one-third had 3 or
more comorbidities (35.7%) and only 10.0% had no
comorbidity. Most of the patients had a long history of
pain, 41.6% had a history of pain for >10 years. Further,
38.8% of the patients did not work at all, whereas only
7.2% worked full time. Besides, 44.8% of the patients did
not participate in any sports at all, although another 19.7%
indulged in sports activities for <1 hour a week.
Changes in Therapy and Activity Parameters
From the Time of Discharge From the Clinic
(Baseline) Until 5-month Follow-up at Home
The majority of the patients was given the same
amount of analgesic and antidepressant medication
throughout the course of outpatient treatment and about
one-third required an increased dose of analgesics over the
course (Table 2). Approximately one-third were able to
increase their level of sports activities. Moreover, 79.7% of
patients attended 1 to 10 consultations at a general prac-
titioner and 61.2% did not consult a psychiatrist or psy-
chologist. Patients had an average of 18.7 lessons of active
physiotherapy whereby the variance was large (from 0
therapies to 204). They had a mean of 12.1 lessons of
passive physiotherapies with a smaller variance.
Changes in Continuous Scores From the Time of
Discharge From the Clinic (Baseline) Until
5-month Follow-up at Home
On average, patients reported slight worsening of
health and coping in almost all assessed scores, whereas the
changes were close to 0 (Table 3). Except in MPI pain
severity and HADS depression, the effect sizes were larger
(0.26 and 0.25). CSQ catastrophizing and working
capacity improved slightly. The variance of the changes was
high for all scores (see SD of change).
Further, 76.3% reported the intention to be more
active in the future regarding sports, physiotherapy, or
movement in everyday life (Table 1). These data were
obtained 2 months after completion of the inpatient reha-
bilitation program. In contrast, MPI activity slightly
deteriorated as shown in Table 3. Even so, 38.2% reported
TABLE 1. Sociodemographic and Disease-relevant Data at
Baseline (n= 291)
n (%)
Sex, female 233 (80.1)
Education
Basic school 76 (26.1)
Vocational training 158 (54.3)
College/high school/university 57 (19.5)
Living with partner 225 (77.3)
Smoker 96 (33.0)
Working capacity (h/wk)
0 113 (38.8)
1-10 27 (9.1)
11-20 38 (13.0)
21-30 65 (22.2)
31-40 25 (8.4)
>40 22 (7.2)
History of pain (y)
<1 20 (6.9)
1-<2 30 (10.3)
2-<5 58 (19.9)
5-<10 62 (21.3)
Z10 121 (41.6)
Age (y)
Mean, SD 50 (12.0)
Minimum, maximum 20 (83.2)
Body Mass Index (kg/m2)
Mean, SD 26 (4.8)
Minimum, maximum 16 (49.5)
Comorbidities
None 29 (10.0)
1 64 (22.0)
2 94 (32.3)
3 or more 104 (35.7)
Diagnosis
Low back pain 196 (67.4)
Widespread pain 95 (32.6)
MPI subgroup
Adaptive Coper 106 (36.4)
Dysfunctional 105 (36.1)
Interpersonally Distressed 73 (25.1)
Sport hours per week
0 130 (44.8)
0-1 57 (19.7)
1-2 58 (20.0)
>2 45 (15.5)
Intention to be active in future*
No 69 (23.7)
Physiotherapy 30 (10.3)
Motion in daily life 66 (22.7)
More sports 126 (43.3)
Analgesics (paracetamol, NSAIDs, opioides, opiates, metamizol)
Yes 147 (50.5)
No 144 (49.5)
Antidepressants (tricyclics, mianserin, mirtazapin, SSRI, SNRI)
Yes 130 (44.7)
No 161 (55.3)
*These data were provided 2 months after discharge from inpatient
rehabilitation.
MPI indicates Multidimensional Pain Inventory; NSAID, nonsteroidal
anti-inflammatory drug; SNRI, serotonin and norepinephrine reuptake
inhibitor; SSRI, selective serotonin reuptake inhibitors.
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an increased sports quota during the 5-month follow-up at
home, and 45.5% reported no change in sports activities
(Table 2).
Regression Model of Change in MPI Pain
Severity From the Time of Discharge From the
Clinic (Baseline) Until 5-month Follow-up at
Home
Table 4 shows the relevant parameters of the linear
regression model for change in pain severity. The most
important variable was the change in HADS anxiety
between baseline and follow-up, and it explained 20.7% of
the variance. This means that the decrease in anxiety was
associated with pain relief. Moreover, 16.9% of the var-
iance was explained by the MPI pain severity score at
baseline. In other words, patients with high levels of pain
were more likely to experience higher pain relief than those
with little pain. HADS depression at baseline explained an
additional 5.5%, that is, mild depression at baseline was
associated with greater pain relief when compared with high
levels of depression. The final model showed a good fit for
pain relief and explained 56.1% of the variance.
No significant predictive impact was found with
respect to age, living with partner, smoker, sex, comor-
bidities, diagnosis, the MPI subgroups (Adaptive Coper,
Dysfunctional, and Interpersonally Distressed), sports
quota at baseline and change (baseline to follow-up),
intention to be active, change of analgesics, use of anti-
depressants, number of consultations of general practi-
tioner and psychiatrist/psychologist, number of active and
passive physiotherapies, CSQ control pain, CSQ cata-
strophizing, CSQ decrease pain, and change in HADS
depression.
Regression Model of Change in SF-36 Physical
Functioning From the Time of Discharge From
the Clinic (Baseline) Until 5-month Follow-up at
Home
Table 5 shows the relevant parameters of the linear
regression model for change in physical functioning. The
most important variable was the change in HADS anxiety
that explained 13.3% of the variance. Decrease in anxiety was
correlated with better physical functioning. A variance of
10.7% was explained by the SF-36 physical functioning
score at baseline. This means that patients with low physical
functioning experienced a higher increase. The HADS
depression score baseline explained 7.1% of the variance,
whereas a low level of depression was correlated with
increase of physical function. The final model showed a
TABLE 2. Therapies and Change of Activity (Discharge From
Clinic Until 5-month Follow-up at Home)
No. Patients (% of Patients)
Change in sports
Reduced 46 (15.9)
No change 132 (45.5)
Augmented 111 (38.2)
No. consultations GP during observation period
0 46 (15.8)
1-5 136 (46.7)
6-10 96 (33.0)
>10 11 (3.8)
No. consultations psychiatrist/psychologist during observation
period
0 178 (61.2)
1-5 59 (20.3)
6-10 50 (17.2)
>10 4 (1.4)
Change in analgetics (paracetamol, NSAIDs, opioides, opiates,
metamizol)
Reduced 17 (5.8)
No change 176 (60.5)
Augmented 98 (33.7)
Change in antidepressants (tricyclics, mianserin, mirtazapin, SSRI,
SNRI)
Reduced 52 (17.9)
No change 209 (71.8)
Augmented 30 (10.3)
No. of active physiotherapies during the observation period
0 102 (35.5)
1-10 50 (17.2)
11-20 44 (15.3)
21-40 55 (19.2)
>40 36 (11.5)
No. of passive physiotherapies during the observation period
0 126 (43.3)
1-10 57 (19.6)
11-20 46 (15.8)
21-40 45 (14.3)
>40 17 (5.3)
GP indicates general practitioner; NSAID: nonsteroidal anti-inflam-
matory drug; SNRI, serotonin and norepinephrine reuptake inhibitor; SSRI,
selective serotonin reuptake inhibitors.
TABLE 3. Outcome Scores in the Course of Treatment
Entry in
Clinic
Discharge From
Clinic Entry-Discharge
5mo Follow-up at
Home Discharge-5mo Follow-up
Mean SD Mean SD ES Mean SD ES
MPI pain severity 26.0 16.0 38.1 19.0 0.76 33.1 20.4 0.26
SF-36 physical functioning 41.6 20.6 50.1 22.0 0.41 49.3 23.2 0.04
MPI activity 39.8 13.0 41.7 15.1 0.15 40.3 14.7 0.09
CSQ catastrophizing 48.9 19.6 54.8 19.8 0.30 55.0 20.8 0.01
CSQ decrease pain 38.8 19.5 46.2 19.6 0.38 42.5 22.8 0.19
CSQ control pain 46.3 21.5 53.0 20.2 0.31 51.1 22.9 0.09
HADS depression 59.5 20.2 66.8 22.0 0.36 61.2 24.0 0.25
HADS anxiety 53.6 21.3 59.8 21.6 0.29 59.1 22.9 0.03
Working capacity (h) 15.1 15.5 15.8 15.9 0.05
CSQ indicates coping strategies questionnaire; ES, effect size; HADS, hospital anxiety and depression scale; MPI, multidimensional pain inventory; SF-36,
short form 36.
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good fit for functional improvement and explained 41% of
the variance.
We found no relevant correlation with education, age,
sex, sports, living with a partner, smoking, body mass
index, comorbidities, diagnosis (low back pain or wide-
spread pain), MPI subgroups, working capacity, sports
(baseline and change), intention to be active, change in
analgesics or antidepressant, number of consultations of
psychiatrist/psychologist or general practitioner, number of
active or passive physiotherapies or CSQ decrease and
control pain, difference and baseline value of MPI activity,
and difference of CSQ catastrophizing.
DISCUSSION
This study examined the statistically predictive impact
of various cofactors on pain relief and improvement of
physical function in chronic pain patients immediately after
discharge from inpatient rehabilitation until the 5-month
follow-up at home. Relief from anxiety with improvement
of both outcomes was the most important and consistent
cross-sectional association. The second most important
cofactor was the baseline level (at discharge from the clinic)
of each dependent variable having a prognostic importance;
a high level of pain or disability predicted greater
improvement in pain and function. One explanation may be
the “regression to the mean” effect. In third place was the
baseline depression; low depression consistently predicted
improvement in pain and function. Further, important
predictors were the coping dimensions catastrophizing and
ability to decrease pain: better coping predicted pain relief
and improved function, although it cannot be determined
whether a high level of anxiety, depression and catas-
trophizing, and a low level of capacity to decrease and
control pain is the reason for higher pain severity or
whether it is the other way round (chicken-egg problem).
The findings described above accord with a cross-sec-
tional evaluation of chronic pain.27 A high level of CSQ
catastrophizing was positively correlated with high pain
intensity, disability, and psychological distress. Other
studies have also reported the importance of psychological
factors (especially depression, anxiety, and catastrophizing)
in the development of pain severity and physical function-
ing.3,12,21 Multidisciplinary outpatient treatment (including
TABLE 4. Regression Model for Change in MPI Pain Severity and Physical Functioning is Excluded as an Independent Variable (56.1%
Explained Variance)
Variables
Change
R2
Change
F
Regression
Coefficient
Significant
P
Bivariate
Correlation
Partial
Correlation
Constant 6.28 0.09
HADS anxiety Difference 0.207 70.6 0.28 <0.001 0.46 0.28
MPI pain severity Baseline 0.169 72.6 0.69 <0.001 0.46 0.60
HADS depression Baseline 0.055 25.7 0.12 0.028 0.15 0.14
CSQ catastrophizing Difference 0.047 24.2 0.33 <0.001 0.44 0.29
CSQ decrease pain Difference 0.017 9.1 0.16 <0.001 0.29 0.23
CSQ decrease pain Baseline 0.016 8.9 0.12 0.017 0.13 0.15
CSQ catastrophizing Baseline 0.013 7.4 0.17 0.01 0.18 0.16
Antidepressants Difference 0.011 6.2 3.77 0.01 0.09 0.15
Working capacity Baseline 0.009 5.4 0.13 0.03 0.09 0.14
Working capacity Difference 0.007 3.8 0.20 0.004 0.10 0.18
Education 0.005 3.0 1.58 0.063 0.08 0.12
No. active
physiotherapies
From baseline to
follow-up
0.005 2.8 0.05 0.093 0.05 0.10
Antidepressant indicates tricyclics, mianserin, mirtazapin; CSQ, coping strategies questionnaire; HADS, hospital anxiety and depression scale; MPI,
multidimensional pain inventory.
TABLE 5. Regression Model for Change in Physical Functioning, and Pain Intensity is Excluded as an Independent Variable (41.0%
Explained Variance)
Variables
Change
R2
Change
F
Regression
Coefficient
Significant
P
Correlation
of the
0 Order
Partial
Correlation
Constant 1.47 0.811
HADS anxiety Difference 0.133 41.7 0.22 0.002 0.36 0.19
SF-36 physical functioning Baseline 0.107 38.0 0.45 <0.001 0.36 0.51
HADS depression Baseline 0.071 27.9 0.13 0.042 0.00 0.13
Education 0.026 10.4 2.89 0.002 0.15 0.19
No. consultations at GP 0.019 7.9 0.49 0.059 0.12 0.12
MPI activity Difference 0.013 5.6 0.28 0.002 0.26 0.19
MPI activity Baseline 0.014 5.7 0.18 0.014 0.01 0.15
Age 0.010 4.7 0.17 0.029 0.05 0.13
CSQ castastrophizing Difference 0.010 4.3 0.19 0.009 0.29 0.16
CSQ catastrophizing Baseline 0.007 3.0 0.12 0.086 0.05 0.11
CSQ indicates coping strategies questionnaire; GP, general practitioner; HADS, Hospital Anxiety and Depression Scale; MPI, Multidimensional Pain
Inventory; SF-36, Short-Form 36.
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psychotherapy) of fibromyalgia improved functional
capability and reduced symptom severity.28 Chronic
pain patients with comorbid depression derive the max-
imum benefit from multidisciplinary pain therapy including
depression treatment.3,29 They showed better outcomes
in pain intensity and physical functioning compared
with depressive chronic pain patients without adequate
depression treatment. Similarly, our data showed that
increased use of antidepressants correlated with less pain
severity.
The present data found no association between the
number of outpatient consultations at a psychiatrist or a
psychologist with the reduction of pain or disability.
Because only 39.8% of the participants made use of psy-
chotherapy, these findings may be biased. It was further
surprising that the intention to be more active had no
influence on MPI pain severity or SF-36 physical func-
tioning as we would have expected, whereas 38.2% were
able to increase their participation in sports. Education had
a relevant correlation with physical functioning but not
with pain severity. This could mean that patients with
better education are more able to cope with chronic pain in
terms of sustained function, although the pain level is the
same as in those with lower education.
Stratified outcome analysis showed some considerable
differences between the MPI cluster subgroups (Dysfunc-
tional, Interpersonally Distressed, and Adaptive Copers) in
previous studies.15,16 The Interpersonally Distressed and
Adaptive Copers improved much more than those Dys-
functional in pain severity and also in SF-36 physical
functioning, whereas the Dysfunctional subgroup improved
more in SF-36 social functioning. A moderate association
between depression and pain was only found for the
Interpersonally Distressed subgroup of MPI.21 However,
categorization of the participants into the subgroups was
not a significant predictor for the amount of change in pain
or function in the present analysis.
All participating patients had completed an inpatient
interdisciplinary rehabilitation program before the obser-
vation period of the present study. After this intervention,
most of the outcomes and cofactors showed relatively high
improvements.7,12 This fact may explain the slight deterio-
ration of many variables during outpatient treatment after
discharge. It may be possible that in patients with chronic
pain, the relationship between affective variables, physical
functioning, and pain intensity/severity might change (eg,
loosen somewhat) after a successful therapy, for example,
by coping instructions. Consequently, this might have an
effect on the strength of correlation between these factors.
To our knowledge, there is no literature that examined this
question. However, both models (Tables 4 and 5) showed
high levels of explained variances, meaning that the asso-
ciations were strong during outpatient management.
Strengths of the study are the relatively large sample
size and the quality of the standardized self-assessments.
Furthermore, the number of potential confounders that
were included in the regression was large. This led to a
comprehensive measurement of potential disease-modifying
factors that explained a high proportion of the variance in
the final models. The limitations of this study were as fol-
lows: the regression model resulted in predictive data for
the whole group of patients and symptom patterns. How-
ever, patients showed high variance, so it may be difficult to
quantify predictive data for a single patient. The 28% drop-
out rate at the 5-month follow-up at home may have led to
some selection bias. There is a risk of false responses
because much of the data are self-assessed.
In conclusion, anxiety, depression, and catastrophiz-
ing play an important role in pain severity and physical
functioning during inpatient rehabilitation and also during
outpatient treatment immediately after the inpatient pain
program until the 5-month follow-up at home. It is
important to assess and treat these dimensions of the
chronic pain syndrome. As there is no literature examining
outpatient therapeutic effects right after a pain program,
there is a need for further studies to focus on follow-up
assessment during outpatient management.
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